CNAO joins the "EURACAN" network for rare tumours

Published on

treatment room at CNAO
Access to treatment at CNAO. (Image credit: CNAO)

OMA partner Centro Nazionale di Adroterapia Oncologica (CNAO) has joined EURACAN-European Rare Adult Cancers Network, the network for solid tumours in adults promoted by the European Union, which brings together 75 highly specialized cancer centres from 24 countries.

With the experience gained over the years in the treatment of rare head and neck tumours, bone and soft tissue sarcomas, CNAO was selected to be part of the EURACAN network, which comprises important treatment and research centres such as the Centre Léon Bérard (Lyon, France), the Istituto Nazionale dei Tumori (Milan, Italy) and Institut Curie (Paris, France).

EURACAN's goal is to improve the diagnosis, therapies and research on rare adult cancers with attention to the assistance and care of those affected. Within the network, CNAO will collaborate with other institutes focusing on bone and soft tissue sarcomas, as well as on rare head and neck tumors.

EURACAN is part of the European Reference Networks (ERNs), virtual networks for collaboration and sharing of specialist skills on rare or complex pathologies, promoted by the European Commission since 2017.

More information: